Abstract

Certain species of genus Caralluma (Asclepiadaceae) are edible and form part of the traditional medicine system of many countries. Caralluma sinaica A.Berger, growing wild in the western region of Saudi Arabia, is used by locals as a remedy to treat diabetes [1]. Pregnane glycosides, the key phytochemical ingredients in Caralluma, are drawing much attention in recent years because of their antitumor and anticancer activities [2]. Thirteen pregnane glycosides, including six new (Fig.1), were isolated from the cytotoxic chloroform extract of the titled plant using repeated normal and reversed phase chromatographic techniques. The structures of the isolated compounds were characterized using extensive spectroscopic techniques including 1D and 2D microflowNMR methods for compounds available in restricted amount. A detailed profiling of the constituents was obtained by UHPLC-ESI-TOF/MS data [3]. Some isolated compounds were evaluated for their in vitro cytotoxic activity, and quinone reductase induction was also assessed.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.